NCT01491893View on ClinicalTrials.gov

PVSRIPO for Recurrent Glioblastoma (GBM)

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 25, 2012

Primary Completion Date

June 27, 2017

Study Completion Date

October 1, 2021

Conditions
GBMGlioblastomaGliomaMalignant Glioma
Interventions
BIOLOGICAL

Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)

Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Brain Tumor Research Charity Grant

UNKNOWN

collaborator

Duke University

OTHER

lead

Istari Oncology, Inc.

INDUSTRY

NCT01491893 - PVSRIPO for Recurrent Glioblastoma (GBM) | Biotech Hunter | Biotech Hunter